RALEIGH, N.C. and DURHAM, N.C., July 22, 2019 /PRNewswire/ — Arbour Group LLC, a global provider of regulatory compliance services for the life sciences industry, has named industry executive Dominic Mancini as their new Vice President of Business Development. Dominic brings 16 plus years of experience in the biotech, pharma and medtech industries. His expertise expands across clinical services, product development and R&D intelligence, creating a vast network of service-oriented client relationships.
Mancini will be responsible for building Arbour’s footprint in the Raleigh-Durham biotech, pharma and medtech communities and beyond into the broader southeast market. “North Carolina is home to many emerging life science R&D innovators, pharmaceutical manufacturers, medical device and contract research organizations,” Mancini notes. “With over 20 years of global compliance experience, exceptional delivery performance and outstanding customer service, Arbour Group is prepared to support this region’s evolving life science software technology systems toward compliance with all applicable regulations.”
“I’m excited for Dominic to join the Arbour team,” said Ahsan Raza, President of Arbour Group. “His integrated business development, sales experience and scalable marketing methods will help us capitalize on the strength of Arbour products and services.” Arbour Group will be opening a Raleigh-Durham office to be located at the North Carolina Biotechnology Center in the Research Triangle Park. With Dominic’s local presence, this move will mark a notable presence for Arbour Group in support of planned growth strategies in NC.
Media Contact: Angelica Perez 3122075816 aperez@arbourgroup.com
Related Links
View original content:http://www.prnewswire.com/news-releases/arbour-group-expands-its-regulatory-compliance-footprint-in-research-triangle-park-300888359.html
SOURCE Arbour Group
Silexion’s Revolutionary RNAi approach demonstrates powerful anti-tumor activity across three major KRAS-driven cancer types; Inhibition…
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader…
Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or…
Parexel also launching a comprehensive Radiopharmaceuticals report at the meeting Onsite Parexel experts include recently…
Lantern also announces clinical team and partner expansion to deliver accelerated treatmentDALLAS, May 29, 2025…
IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
